Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Avid Bioservices (CDMO) stocks in Canada

Learn how to easily invest in Avid Bioservices stocks.

Avid Bioservices is a biotechnology business based in the US. Avid Bioservices stocks (CDMO.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $26.62 – a decrease of 13.21% over the previous week. Avid Bioservices employs 252 staff and has a trailing 12-month revenue of around $106.3 million.

How to buy shares in Avid Bioservices

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CDMO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Avid Bioservices stock price (NASDAQ:CDMO)

Use our graph to track the performance of CDMO stocks over time.

Avid Bioservices shares at a glance

Information last updated 2022-01-17.
Latest market close$18.20
52-week range$12.60 - $34.51
50-day moving average $28.73
200-day moving average $24.67
Wall St. target price$32.67
PE ratio 154.1912
Dividend yield N/A (0%)
Earnings per share (TTM) $0.14

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Avid Bioservices stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Avid Bioservices price performance over time

Historical closes compared with the close of $18.2 from 2022-01-21

1 week (2022-01-13) -12.25%
1 month (2021-12-18) N/A
3 months (2021-10-18) N/A
6 months (2021-07-22) -28.91%
1 year (2021-01-22) 27.72%
2 years (2020-01-22) 183.05%
3 years (2019-01-22) 405.56%
5 years (2017-01-20) 6,226.03%

Is Avid Bioservices under- or over-valued?

Valuing Avid Bioservices stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Avid Bioservices's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Avid Bioservices's P/E ratio

Avid Bioservices's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 154x. In other words, Avid Bioservices shares trade at around 154x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Avid Bioservices's EBITDA

Avid Bioservices's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $20.2 million.

The EBITDA is a measure of a Avid Bioservices's overall financial performance and is widely used to measure a its profitability.

Avid Bioservices financials

Revenue TTM $106.3 million
Operating margin TTM 15.39%
Gross profit TTM $29.3 million
Return on assets TTM 4.92%
Return on equity TTM 27.91%
Profit margin 13.2%
Book value $0.83
Market capitalisation $1.3 billion

TTM: trailing 12 months

Avid Bioservices share dividends

We're not expecting Avid Bioservices to pay a dividend over the next 12 months.

Have Avid Bioservices's shares ever split?

Avid Bioservices's shares were split on a 1:7 basis on 9 July 2017. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Avid Bioservices shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Avid Bioservices shares which in turn could have impacted Avid Bioservices's share price.

Avid Bioservices share price volatility

Over the last 12 months, Avid Bioservices's shares have ranged in value from as little as $12.6 up to $34.51. A popular way to gauge a stock's volatility is its "beta".

CDMO.US volatility(beta: 2.3)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Avid Bioservices's is 2.2955. This would suggest that Avid Bioservices's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Avid Bioservices overview

Avid Bioservices, Inc. , a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc.

Stocks similar to Avid Bioservices

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site